Post Resch Tallon Group Inc. Codexis, Inc. Transaction History
Post Resch Tallon Group Inc.
- $104 Billion
- Q2 2025
A detailed history of Post Resch Tallon Group Inc. transactions in Codexis, Inc. stock. As of the latest transaction made, Post Resch Tallon Group Inc. holds 467,301 shares of CDXS stock, worth $1.21 Million. This represents 1.1% of its overall portfolio holdings.
Number of Shares
467,301
Previous 468,587
0.27%
Holding current value
$1.21 Million
Previous $1.16 Billion
1.29%
% of portfolio
1.1%
Previous 1.18%
Shares
3 transactions
Others Institutions Holding CDXS
# of Institutions
139Shares Held
63.7MCall Options Held
37.7KPut Options Held
25.9K-
Opaleye Management Inc. Boston, MA9.5MShares$24.5 Million7.03% of portfolio
-
Casdin Capital, LLC New York, NY8.1MShares$20.9 Million2.55% of portfolio
-
Black Rock Inc. New York, NY6.79MShares$17.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.72MShares$12.2 Million0.0% of portfolio
-
Telemark Asset Management, LLC Boston, MA3MShares$7.74 Million1.17% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $169M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...